Normalization Of Postreatment SCC Ag As A Prognostic Marker In Patients With Advanced Cervical Cancer Treated With First-Line Bevacizumab-Paclitaxel-Cisplatin Therapy

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.